Emil D. Kakkis - President & CEO, Director at Ultragenyx Pharmaceutical Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Issuer Symbol
RARE on Nasdaq
All Insider Reports
All Insider Reports

Emil D. Kakkis - trading volume in the past year for Ultragenyx Pharmaceutical Inc.

Holdings reported by Emil D. Kakkis for Ultragenyx Pharmaceutical Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,158,985 $48,663,521 $22.54 01 Mar 2026 By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009
Common Stock 658,994 $15,025,063 $22.80 02 Mar 2026 Direct
Stock Option (Right to Buy) 78,448 01 Mar 2025 Direct Common Stock

Transactions reported by Emil D. Kakkis for Ultragenyx Pharmaceutical Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.